{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:04:03Z","timestamp":1792101843220,"version":"4.4.0"},"reference-count":5,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.2337\/dc26-0165","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:35:19Z","timestamp":1781274919000},"page":"e138-e139","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":2,"title":["Study of Metformin and GLP-1 Receptor Agonist Use in Hidradenitis Suppurativa Using the NIH All of Us Research Program"],"prefix":"10.2337","volume":"49","author":[{"given":"Raslina","family":"Shrestha","sequence":"first","affiliation":[{"name":"Department of Dermatology, Mayo Clinic 1 , Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic 1 , Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-3183","authenticated-orcid":false,"given":"Rozalina G.","family":"McCoy","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes Nutrition, Department of Medicine, University of Maryland School of Medicine 2 , Baltimore, MD"},{"name":"University of Maryland Institute for Health Computing 3 , North Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026072014520706000_B1","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/ijd.14500","article-title":"Hidradenitis suppurativa and metabolic syndrome - systematic review and adjusted meta-analysis","volume":"58","author":"Phan","year":"2019","journal-title":"Int J Dermatol"},{"key":"2026072014520706000_B2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2026072014520706000_B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2018.01.014","article-title":"Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2026072014520706000_B4","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.3390\/jcm13216292","article-title":"The therapeutic potential of GLP-1 receptor agonists in the management of hidradenitis suppurativa: a systematic review of anti-inflammatory and metabolic effects","volume":"13","author":"Krajewski","year":"2024","journal-title":"J Clin Med"},{"key":"2026072014520706000_B5","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3390\/ijms24086969","article-title":"Metformin treatment of hidradenitis suppurativa: effect on metabolic parameters, inflammation, cardiovascular risk biomarkers, and immune mediators","volume":"24","author":"Hambly","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/e138\/885838\/dc260165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/e138\/885838\/dc260165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:52:14Z","timestamp":1784573534000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/8\/e138\/172037\/Study-of-Metformin-and-GLP-1-Receptor-Agonist-Use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":5,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0165","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}